Energisme SA

02/17/2022 | Press release | Distributed by Public on 02/17/2022 11:03

ENERGISME: E-Health: the Universities of Nice Côte d'Azur and Rouen choose Loamics and its partner MyDataModels to collect, process and analyse medical data and improve patient[...]

ENERGISME: E-Health: the Universities of Nice Côte d'Azur and Rouen choose Loamics and its partner MyDataModels to collect, process and analyse medical data and improve patient journeys.

Subscribe

17 Feb 2022 17:52 CET

Company Name

ENERGISME

ISN

FR0013399359

Market

Euronext Growth

Symbol

ALNRG

ENERGISME
ENERGISME: E-Health: the Universities of Nice Côte d'Azur and Rouen choose Loamics and its partner MyDataModels to collect, process and analyse medical data and improve patient journeys.

17-Feb-2022 / 17:52 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

E-Health: the Universities of Nice Côte d'Azur and Rouen choose Loamics and its partner MyDataModels to collect, process and analyse medical data and improve patient journeys

The teaching and general research departments of the Universities of Côte d'Azur and Rouen, in partnership with the DERMG (Department of Teaching and Research in General Medicine), use Loamics and MyDataModels for the analysis and processing of medical data. This initiative is the first stage in the PRIMEGE (Regional General Medicine Information Platform) project, which aims to collect anonymised data directly from the consultation software, without any effort on the part of the doctor, in order to build a database for research and evaluation of practices in general medicine.

It is currently very difficult to consolidate and analyse medical data in a global and relevant way since it comes from various software applications, which do not communicate with each other and only partially with the public health service. The non-interoperability of systems and the diversity, volume, security, governance and personal nature of medical data are all major challenges to be met in order to obtain the quality data that is an essential prerequisite for reliable analyses.

That is why the two Universities of Côte d'Azur and Rouen are using the solution offered by Loamics and MyDataModels. Loamics is a software publisher and has developed a PaaS software suite to address data issues. The Loamics platform is a very powerful infrastructure capable of processing huge masses of varying data types, continuously or in real time, through a fully automated, industrialised process. The system is interoperable, able to connect to any data source and handle any transmission protocol, to make the data more reliable and uniform. Once the intelligence of the data has been revealed, it is ready to be submitted to the artificial intelligence and predictive modelling platform developed by MyDataModels.

This project is being rolled out on a private cloud certified for its compliance with the French government's HDS (Health Data Hosting) standard, enabling it to respond to all security issues.

David Darmon, a doctor, Director of the DERMG and Professor at the University of Côte d'Azur, says, "Today, in France, we are not exploiting the potential of medical data. We started by launching a pilot with Loamics which proved to be very conclusive and its results made us decide to entrust the project to Loamics and MyDataModels. Our ambition is simple, to enhance the data at our disposal to improve diagnosis, accelerate research and ensure personal patient care, while ensuring the maximum security of this data which we know to be sensitive."

Stéphane Bollon, CEO of Loamics, adds, "Thank you to David Darmon, Matthieu Schuers (1) and Stefan Darmoni (2) for their confidence and for their ambition. Loamics is a solution that cuts across all business sectors. In the healthcare field, one of its differentiating advantages lies in our ability to manage metadata, which makes it very easy to anonymise data and overcome security challenges. We offer a solution that is unique on the market and we are confident in our ability to move forward with companies that have tested our solution and are unanimous on the value provided.

  1. Matthew Schuers, lecturer at the University of Rouen and General Practitioner
  2. Stephane Darmoni, Professor of Medicine at Rouen University Hospital

ABOUT ENERGISME

ENERGISME has developed a SaaS software solution, N'gage, aimed at accelerating the energy performance of companies (energy service providers, energy suppliers and distributors, industrialists and property managers) thanks to data intelligence, as well as a PaaS platform, Loamics, dedicated to real-time processing of massive and heterogeneous data. With the decisive technological and operational advantages of its platform, ENERGISME already has more than 170 major customers. The solution is also marketed by leading players under white label. ENERGISME (ISIN Code: FR0013399359/ Mnemonic: ALNRG) has been listed since July 2020 on the Euronext Growth market.

ENERGISME is a company eligible for the PEA-PME, and is also qualified as a BPI Innovative Company and BPI Excellence.

More information : https://energisme.com/investisseurs/

CONTACTS

ENERGISME

Sandrine Chauvin

[email protected]

Tel. +33 (1) 81 89 33 90

Press

Jennifer Jullia

[email protected]

Tel. +33 (1) 56 88 11 19

Investors

Stéphane Ruiz

[email protected]

Tel. +33 (1) 56 88 11 26

Regulatory filing PDF file

File: Energisme - E-Health UK


1282723 17-Feb-2022 CET/CEST

XRBLQYTQBHLVPRFJAECARCOC_ENERGISME-CP-20220217-EN.pdf

Source

ENERGISME

Provider

EQS Group